Anxiety in the “Age of Hypertension”

Current Hypertension Reports

Volumn 16, Issue 10, 2014, Pages

  Byrd, James Brian ^a   Brook, Robert D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Anxiety; Blood pressure; Hypertension; Hyperventilation; Pseudopheochromocytoma

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ANXIETY; ANXIETY DISORDER; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CHRONIC STRESS; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; HYPERVENTILATION; LIFESTYLE MODIFICATION; MEDICAL SOCIETY; MEDICATION COMPLIANCE; MEDITATION; NATURAL DISASTER; NOCEBO EFFECT; PATIENT COMPLIANCE; PHEOCHROMOCYTOMA; PSEUDOPHEOCHROMOCYTOMA; RELAXATION TRAINING; RESISTANT HYPERTENSION; REVIEW; THERAPY EFFECT; WHITE COAT HYPERTENSION; ANXIETY DISORDERS; BLOOD PRESSURE MEASUREMENT; COMPLICATION; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROCEDURES; UNITED STATES;

ANXIETY; ANXIETY DISORDERS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; STRESS, PHYSIOLOGICAL; UNITED STATES;

EID: 84930278705     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0486-0     Document Type: Review

References (56)

1. Auden WH, Jacobs A. The age of anxiety: a Baroque Eclogue: Princeton University Press; 2011.
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):617–27. PMCID: Pmc2847357.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circ. 2014;129(3):e28–e292.
4. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058. PMCID: Pmc2667673.
5. Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15(3):134–6. PMCID: Pmc3699411.
6. Kessler RC, Ormel J, Demler O, Stang PE. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med. 2003;45(12):1257–66.
7. Sparrenberger F, Cichelero FT, Ascoli AM, Fonseca FP, Weiss G, Berwanger O, et al. Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens. 2009;23(1):12–9.
8. Spruill TM. Chronic psychosocial stress and hypertension. Curr Hypertens Rep. 2010;12(1):10–6. PMCID: Pmc3694268.
9. Gasperin D, Netuveli G, Dias-da-Costa JS, Pattussi MP. Effect of psychological stress on blood pressure increase: a meta-analysis of cohort studies. Cadernos de Saude Publica. 2009;25(4):715–26.
10. Mann SJ. Psychosomatic research in hypertension: the lack of impact of decades of research and new directions to consider. J Clin Hypertens (Greenwich). 2012;14(10):657–64. This review focuses on factors limiting the impact of research on anxiety as it relates to hypertension.
11. Weiner IB, Craighead WE. The Corsini Encyclopedia of Psychology: Wiley; 2010.
12. American Psychiatric Association APADSMTF. Diagnostic and statistical manual of mental disorders: DSM-5. 2013 [updated 2013; cited]; Available from: http://dsm.psychiatryonline.org/book.aspx?bookid=556.
13. Ascher LM, Schotte DE. Paradoxical intention and recursive anxiety. J Behav Ther Exp Psychiatry. 1999;30(2):71–9.
14. Palatini P, Bratti P, Palomba D, Saladini F, Zanatta N, Maraglino G. Regular physical activity attenuates the blood pressure response to public speaking and delays the development of hypertension. J Hypertens. 2010;28(6):1186–93.
15. Palatini P, Bratti P, Palomba D, Bonso E, Saladini F, Benetti E, et al. BP reactivity to public speaking in stage 1 hypertension: influence of different task scenarios. Blood Press. 2011;20(5):290–5.
16. Palatini P, Palomba D, Bertolo O, Minghetti R, Longo D, Sarlo M, et al. The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. J Hypertens. 2003;21(3):545–53.
17. Lynch JJ, Long JM, Thomas SA, Malinow KL, Katcher AH. The effects of talking on the blood pressure of hypertensive and normotensive individuals. Psychosom Med. 1981;43(1):25–33.
18. White WB, Baker LH. Episodic hypertension secondary to panic disorder. Arch Intern Med. 1986;146(6):1129–30.
19. Davies SJ, Ghahramani P, Jackson PR, Noble TW, Hardy PG, Hippisley-Cox J, et al. Association of panic disorder and panic attacks with hypertension. Am J Med. 1999;107(4):310–6.
20. CDC. High blood pressure. [cited]; Available from: http://www.cdc.gov/bloodpressure/.
21. Spruill TM, Pickering TG, Schwartz JE, Mostofsky E, Ogedegbe G, Clemow L, et al. The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med. 2007;34(1):1–9.
22. Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med. 1997;6(1):43–9.
23. Barringer 3rd TA. The tension in hypertension. Arch Fam Med. 1997;6(1):50–1.
24. Hildrum B, Mykletun A, Stordal E, Bjelland I, Dahl AA, Holmen J. Association of low blood pressure with anxiety and depression: the Nord-Trondelag Health Study. J Epidemiol Community Health. 2007;61(1):53–8. PMCID: 2465598.
25. Hildrum B, Romild U, Holmen J. Anxiety and depression lowers blood pressure: 22-year follow-up of the population based HUNT study, Norway. BMC Public Health. 2011;11:601. PMCID: 3162525.
26. Flaa A, Eide IK, Kjeldsen SE, Rostrup M. Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertens. 2008;52(2):336–41.
27. Steimer T. Animal models of anxiety disorders in rats and mice: some conceptual issues. Dialogues Clin Neurosci. 2011;13(4):495–506. PMCID: Pmc3263396.
28. Gerin W, Chaplin W, Schwartz JE, Holland J, Alter R, Wheeler R, et al. Sustained blood pressure increase after an acute stressor: the effects of the 11 September 2001 attack on the New York City World Trade Center. J Hypertens. 2005;23(2):279–84.
29. Petrazzi L, Striuli R, Polidoro L, Properzi G, Casale R, Pasqualetti P, et al. Changes in 24-h ambulatory blood pressure monitoring during the 2009 earthquake at L’Aquila. Am J Med. 2010;123(10):e1–3.
30. Arcaya M, Glymour MM, Chakrabarti P, Christakis NA, Kawachi I, Subramanian SV. Effects of proximate foreclosed properties on individuals’ systolic blood pressure in Massachusetts, 1987 to 2008. Circ. 2014;129(22):2262–8. PMCID: Pmc4098719. This interesting study demonstrated a graded relationship between nearby foreclosures and blood pressure.
31. Yasunari K, Matsui T, Maeda K, Nakamura M, Watanabe T, Kiriike N. Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension. Am J Hypertens. 2006;19(6):573–8.
32. Piccirillo G, Viola E, Nocco M, Santagada E, Durante M, Bucca C, et al. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertens. 1999;34(2):242–6.
33. Saito II, Takeshita E, Murata K, Kawabe H, Saruta T. Serum cortisol in the white-coat phenomenon. Blood Press Monit. 1996;1(4):381–3.
34. Byrd JB, Powers JD, Magid DJ, Tavel HM, Schmittdiel JA, O’Connor PJ, et al. Detection and recognition of hypertension in anxious and depressed patients. J Hypertens. 2012;30(12):2293–8. This study in large cohort demonstrated earlier detection of elevated blood pressure in patients with anxiety and depression compared to other patients.
35. Hamer M, Batty GD, Stamatakis E, Kivimaki M. Hypertension awareness and psychological distress. Hypertens. 2010;56(3):547–50.
36. Pickering TG. Should white coat hypertension be treated? J Clin Hypertens (Greenwich). 2005;7(9):550–3.
37. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98.
38. Hansen TW, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25(8):1554–64.
39. Ogedegbe G, Pickering TG, Clemow L, Chaplin W, Spruill TM, Albanese GM, et al. The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med. 2008;168(22):2459–65.
40. Davies SJ, Jackson PR, Ramsay LE, Ghahramani P, Palmer RL, Hippisley-Cox J. No evidence that panic attacks are associated with the white coat effect in hypertension. J Clin Hypertens (Greenwich). 2003;5(2):145–52.
41. Starkman MN, Zelnik TC, Nesse RM, Cameron OG. Anxiety in patients with pheochromocytomas. Arch Intern Med. 1985;145(2):248–52.
42. Mann SJ. Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions. Psychosom. 1996;37(5):444–50.
43. Fogarty J, Engel CC, Russo J, Simon G, Katon W. Hypertension and pheochromocytoma testing: the association with anxiety disorders. Arch Fam Med. 1994;3(1):55–60.
44. Kaplan NM. Anxiety-induced hyperventilation. A common cause of symptoms in patients with hypertension. Arch Intern Med. 1997;157(9):945–8.
45. Naschitz JE, Mussafia-Priselac R, Peck ER, Peck S, Naftali N, Storch S, et al. Hyperventilation and amplified blood pressure response: is there a link? J Hum Hypertens. 2005;19(5):381–7.
46. Stern RH. Nocebo responses to antihypertensive medications. J Clin Hypertens (Greenwich). 2008;10(9):723–5.
47. Davies SJ, Jackson PR, Ramsay LE, Ghahramani P. Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients. Arch Intern Med. 2003;163(5):592–600.
48. Khatib R, Schwalm JD, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One. 2014;9(1):e84238. PMCID: Pmc3893097.
49. Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, et al. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012;109(9):1266–71.
50. Bautista LE, Vera-Cala LM, Colombo C, Smith P. Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens. 2012;25(4):505–11. This study found decreased antihypertensive medication adherence in patients with at least mild anxiety and depression symptoms.
51. Davies SJ, Ghahramani P, Jackson PR, Hippisley-Cox J, Yeo WW, Ramsay LE. Panic disorder, anxiety and depression in resistant hypertension—a case–control study. J Hypertens. 1997;15(10):1077–82.
52. Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, et al. Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation. EuroIntervention. 2013;9(6):700–8.
53. Schmieder RE, Grassi G, Kjeldsen SE. Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study. J Hypertens. 2013;31(3):610–5.
54. Grossman E, Nadler M, Sharabi Y, Thaler M, Shachar A, Shamiss A. Antianxiety treatment in patients with excessive hypertension. Am J Hypertens. 2005;18(9 Pt 1):1174–7.
55. Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertens. 2013;61(6):1360–83. This scientific statements reviews the state of the art in non-pharmacological therapies for blood pressure lowering. Stress reduction techniques are discussed in detail.
56. Bradt J, Dileo C, Potvin N. Music for stress and anxiety reduction in coronary heart disease patients. Cochrane Database Syst Rev. 2013;12:Cd006577.